Clinical Trials Directory

Trials / Completed

CompletedNCT03010280

Effect of Immunonutrition on Inflamatory Markers After Bariatric Surgery

A Controlled, Randomized, Open Clinical Trial to Compare the Effect of Preoperatory Treatment With Immunonutrition vs Hyperproteic Nutritional Supplements on Postoperative Inflammation Markers in Patients Going Through Bariatric Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective randomized clinical trial of all the patients undergoing Roux - en-Y gastric bypass will be performed. Patients will be randomly assigned into 2 groups: those patients receiving a preoperative balanced energy high-protein formula (group 1) and those receiving preoperative Immunonutrition (group 2). Changes between groups in acute inflamatory markers, pain, postoperative septic complications and lenght of stay, among others will be investigated.

Detailed description

A prospective randomized clinical trial of all the patients undergoing Roux - en-Y gastric bypass will be performed. Patients will be randomly assigned into 2 groups: those patients receiving a preoperative balanced energy high-protein formula (group 1) and those receiving preoperative Immunonutrition (group 2). Changes between groups in acute inflamatory markers (CRP, fibrinogen, leucocites), pain (VAS scale), postoperative septic complications .(anastomotic leak and organ/space SSI)and lenght of stay, among others will be investigated.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTImmunonutritionBalanced high-protein formula enriched with Omega-3 fatty acids. 200 ml of formula every 8 hours during 10 days preoperatively
DIETARY_SUPPLEMENTBalanced high-protein formulaBalanced high-protein formula, without Omega-3 fatty acids. 200 ml of formula every 8 hours during 10 days preoperatively

Timeline

Start date
2016-02-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2017-01-05
Last updated
2018-02-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03010280. Inclusion in this directory is not an endorsement.